Close

Gilead Sciences (GILD) Tops Q4 EPS by 1c; Authorizes $5B Buyback Plan; Receives 'Refuse to File' Notification from FDA

Go back to Gilead Sciences (GILD) Tops Q4 EPS by 1c; Authorizes $5B Buyback Plan; Receives 'Refuse to File' Notification from FDA